Succinate Modulation as a Novel Mechanism Underlying the Effects of Intermittent Fasting on Brain Function and Metabolism in Diet-Induced Obesity

Obesity significantly impacts the central nervous system (CNS), increasing risks of neuropsychiatric disorders and dementia. Intermittent fasting (IF) shows promise for improving peripheral and CNS health, but its mechanisms are unclear. Using a diet-induced obesity mouse model (10 weeks high fat diet (HFD), then 4 weeks intervention), we compared HFD, HFD-IF, ad libitum control chow (CC), and CC-IF groups. Switching to CC or IF reduced body weight, fat mass, and improved glucose tolerance. Notably, CC-IF uniquely enhanced exploration and reduced anxiety-like behavior. Transcriptomics revealed HFD-induced hippocampal neuroinflammation, while metabolomics identified a specific succinate signature in CC-IF mice: plasma concentration decreased while liver and brown adipose tissue (BAT) levels increased. Succinate supplementation mimicked CC-IF metabolic and behavioral benefits and reduced hippocampal inflammation. These findings suggest that regulating plasma succinate and its metabolism in liver and BAT may represent a novel mechanism underlying the metabolic, neuroinflammatory, and behavioral improvements induced by IF.